)
)
Alpha Tau Medical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Alpha Tau Medical Ltd
Access all reports
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company. The company specializes in the research, development, and commercialization of its proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) technology. This innovative therapy is designed for the treatment of solid tumors, with the ability to deliver highly potent and localized alpha radiation, minimizing damage to surrounding healthy tissues. Alpha Tau is focused on addressing unmet needs in various cancer types, including skin, oral, pancreatic, and prostate cancers, among others. The company is headquartered in Jerusalem, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
DRTS
Country
🇺🇸 United States